Evaluation of effectiveness and safety of transcatheter renal arterial embolization with microspheres for polycystic kidney disease

Not Applicable

• Conditions: Polycystic kidney disease

• Registration Number: JPRN-UMIN000016576
• Lead Sponsor: Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital Clinical Research and Medical Innovation Center, Hokkaido University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-02-23
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

Not provided

Exclusion Criteria

1) Active inflammatory disease 2) Past history of malignant disease (except for carcinoma in situ) within five years before registration 3) Uncontrollded comorbid disease in the kidney, liver or heart. 4) Contraindication to iodized contrast material 5) Allergy to components (acrylic polymer and porcin gelatin) of microspheres (Embosphere) 6) Massive thoracic effusion 7) Massive ascites 8) Past history of renal arterial embolization 9) Hemoglobin < 8g/dL 10) Platelet count < 50,000 /mm3 11) Abnormalities in 12-led electrocardiogram (excluding clinically not significant abnormalities) 12) Pregnant or possibility being pregnant 13) Judged being not suitable by the principal or sub investigators

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The volume reduction rate of the kidneys at three months after renal arterial embolization